Literature DB >> 18375053

ARLTS1 - a novel tumor suppressor gene.

Sai Yendamuri1, Francesco Trapasso, George A Calin.   

Abstract

ARLTS1 (ADP-ribosylation factor-like tumor suppressor gene 1) is a member of the ARF family of the Ras superfamily of small GTPases that are known to be involved in multiple regulatory pathways altered in human carcinogenesis. Here, we review recent work that has provided insights into the role of this small gene as an emerging player in both familial and sporadic cancers of several histotypes. ARLTS1 is a low penetrance gene that is primarily dysregulated in sporadic lung cancer by promoter hypermethylation. Two ARLTS1 polymorphisms are also associated with familial cancer risk. Down-regulation of ARLTS1 is seen in all lung cancer cell lines studied and in a significant proportion (37%) of primary lung tumors. Restoration of ARLTS1 expression in ARLTS1-deficient lung cancer cell lines by either demethylation or adenoviral transduction leads to apoptosis via caspase-dependent mechanisms. Furthermore, ARLTS1 re-expression induces an in vivo decreased tumor growth in preclinical models of lung cancer. Microarray analysis of gene expression patterns in cells transduced with ARLTS1 demonstrates that various pathways involved in cell survival, proliferation and development mediate its pro-apoptotic effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375053     DOI: 10.1016/j.canlet.2008.02.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Clld7, a candidate tumor suppressor on chromosome 13q14, regulates pathways of DNA damage/repair and apoptosis.

Authors:  Xiaobo Zhou; Karl Münger
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  MAPping the kinase landscape of macrophage activation.

Authors:  Khrystyna Platko; Paul Lebeau; Richard C Austin
Journal:  J Biol Chem       Date:  2018-06-22       Impact factor: 5.157

Review 3.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

4.  Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.

Authors:  Anna Abulí; Ceres Fernández-Rozadilla; Virginia Alonso-Espinaco; Jenifer Muñoz; Victoria Gonzalo; Xavier Bessa; Dolors González; Joan Clofent; Joaquin Cubiella; Juan D Morillas; Joaquim Rigau; Mercedes Latorre; Fernando Fernández-Bañares; Elena Peña; Sabino Riestra; Artemio Payá; Rodrigo Jover; Rosa M Xicola; Xavier Llor; Luis Carvajal-Carmona; Cristina M Villanueva; Victor Moreno; Josep M Piqué; Angel Carracedo; Antoni Castells; Montserrat Andreu; Clara Ruiz-Ponte; Sergi Castellví-Bel
Journal:  BMC Cancer       Date:  2011-08-05       Impact factor: 4.430

5.  A Multifaceted Role for Myd88-Dependent Signaling in Progression of Murine Mammary Carcinoma.

Authors:  Mary J Higgins; Antonio Serrano; Kofi Y Boateng; Victoria A Parsons; Tiffany Phuong; Alyssa Seifert; Jacob M Ricca; Kyle C Tucker; Alec S Eidelman; Maureen A Carey; Robert A Kurt
Journal:  Breast Cancer (Auckl)       Date:  2016-10-27

Review 6.  ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.

Authors:  Yan Jiang; Chen-Yang Zhao; Li-Chun Cheng; Bing Xu; Hui-Yi Lv
Journal:  Hered Cancer Clin Pract       Date:  2017-06-13       Impact factor: 2.857

Review 7.  The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective.

Authors:  Cristina Casalou; Andreia Ferreira; Duarte C Barral
Journal:  Front Cell Dev Biol       Date:  2020-04-21

8.  Multi-tissue microarray analysis identifies a molecular signature of regeneration.

Authors:  Sarah E Mercer; Chia-Ho Cheng; Donald L Atkinson; Jennifer Krcmery; Claudia E Guzman; David T Kent; Katherine Zukor; Kenneth A Marx; Shannon J Odelberg; Hans-Georg Simon
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

9.  Identification of KANSARL as the first cancer predisposition fusion gene specific to the population of European ancestry origin.

Authors:  Jeff Xiwu Zhou; Xiaoyan Yang; Shunbin Ning; Ling Wang; Kesheng Wang; Yanbin Zhang; Fenghua Yuan; Fengli Li; David D Zhuo; Liren Tang; Degen Zhuo
Journal:  Oncotarget       Date:  2017-03-24

10.  ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling.

Authors:  Subhash B Arya; Gaurav Kumar; Harmeet Kaur; Amandeep Kaur; Amit Tuli
Journal:  J Biol Chem       Date:  2018-04-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.